Botanix Pharmaceuticals Limited (ASX:BOT)
0.4600
0.00 (0.00%)
Mar 28, 2025, 4:10 PM AEST
Botanix Pharmaceuticals Revenue
Botanix Pharmaceuticals had revenue of 377.60K AUD in the half year ending December 31, 2024, a decrease of -89.83%. This brings the company's revenue in the last twelve months to 2.07M, up 373.26% year-over-year. In the fiscal year ending June 30, 2024, Botanix Pharmaceuticals had annual revenue of 2.07M, down -45.14%.
Revenue (ttm)
2.07M
Revenue Growth
+373.26%
P/S Ratio
n/a
Revenue / Employee
188.10K
Employees
11
Market Cap
839.79M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |
Botanix Pharmaceuticals News
- 2 months ago - This media company’s share price is tipped to double - The Australian Financial Review